Expected Moves

Lepermislibre is expected to report H1 2026 results with a critical focus on cash runway, given the severe structural revenue decline and only $311k in cash at year-end 2025.

Anticipated announcement of an emergency equity dilution or debt restructuring to maintain baseline operations through early 2027.

FY 2026 annual report release, which will serve as a definitive test of Lepermislibre's viability as a standalone public entity.